INTRODUCTION
The Sanfilippo syndromes are autosomal recessive mucopolysaccharidoses characterized by severe mental retardation, mild skeletal deformities, and deposition in tissues and excretion in urine of heparan sulfate. The accumulation of glycosaminoglycans (GAG) 1 in culDr. Matalon is a Joseph P. Kennedy, Jr., Scholar. Received for publication 7 March 1974 and in revised form 5 June 1974. 1 Abbreviation used in this paper: GAG, glycosaminoglycans. tured skin fibroblasts from patients with the Sanfilippo syndromes was reported by Matalon and Dorfman (1) . In that report, heparan sulfate was not detected in cultured normal skin fibroblasts and in fibroblasts obtained from patients with these mucopolysaccharidoses. However, Kresse and Neufeld (2) indicated the presence of a GAG with properties of heparan sulfate in fibroblasts from Sanfilippo A disease. The development by Cifonelli (3) of the nitrous acid method for the degradation of N-sulfated glucosamine-containing GAG has made possible the identification of small amounts of such substances in complex mixtures of GAG. Using this method, Kraemer (4, 5) has shown the presence of heparan sulfate in a number of cultured cell lines. Dorfman and Ho (6) demonstrated the synthesis of heparan sulfate by cultured rat glial tumor cells (RG-C6). All of these findings suggest that our earlier observation was in error and led us to re-examine the question of the presence of heparan sulfate in cultured human skin fibroblasts. This substance was found to represent 1.25% of the GAG in normal fibroblasts and 7-10% in fibroblasts derived from patients with Hurler's, Hunter's, and Sanfilippo diseases. Culture conditions. Skin fibroblasts, which had undergone three to six transfers, were cultured as previously described (14) in modified Eagle's medium (Grand Island Biological Co., Grand Island, N. Y.) supplemented with ascorbic acid (100 mg/liter), streptomycin (75 mg/liter), penicillin (100,000 U/liter), 10%o fetal calf serum, and 10%o calf serum. Under the conditions of these experiments, by using 100 mm Falcon tissue culture dishes under CO2 concentration of 10%o at 37°C, cell density of approximately 1.6 X 107 was achieved in 3 wk. During this time, pH fluctuation of the medium was between 7.2-7.4. Routine monitoring for mycoplasma infection was performed in mycoplasma agar medium (Grand Island Biological Co.). Before harvesting, cells were washed three times with 0.15 M NaCl, scraped from the plate with a rubber policeman, and suspended in 0.05 M acetate buffer in 0.15 M NaCl, pH 4.5.
Isolation of GAG. GAG were isolated from the harvested cells after papain digestion in 0.1 M acetate buffer (pH 5.5) containing 0.005 M disodium ethylenediaminetetraacetate (Fisher Scientific Co., Pittsburgh, Pa.) and 0.005 M cysteine HCl. Digestion was carried out for 18 h at 60'C followed by 24 h dialysis against H20. Under these conditions, the GAG remain intact, although there is a possibility of a loss of small oligosaccharides during dialysis. The crude GAG mixture was precipitated with cetylpyridinium chloride (Sigma Chemical Co., St. Louis, Mo.), as previously described (14) . The GAG was fractionated by chromatography on Dowex 1 X 2 Cl-columns (18 X 1 cm) (Dow Chemical Co., Midland, Mich.) with stepwise NaCl elution (14) . Only fractions eluted with 1.0 and 1.25 M NaCl contained nitrous acid-reactive material. Gel filtration was carried out with Sephadex G-25, superfine (Pharmacia Fine Chemicals, Inc., Piscataway, N. J.), on 180 X 1.0-cm columns.
Analysis and identification of GAG. Uronic acid was estimated by the method of Dische (15) . N-Sulfated hexosamine was determined by a micromodification of the method of Lagunoff and Warren (16) by utilizing a final volume of 1.0 ml instead of 6.2 ml. This scaling down of volume leads to more sensitive assay, so that 1.0 ;ig of N-sulfated hexosamine can be detected. Amino sugars were determined by a Technicon amino acid analyzer (Technicon Instruments Corp., Tarrytown, N. Y.). Electrophoresis was performed on Sepraphore III (Gelman Instrument Co., Ann Arbor, Mich.) at pH 3.0 by using formic acid:pyridine buffer, as previously described (14) . The purified heparan sulfate fractions were subj ected to digestion with chondroitinase ABC (Seikagaku, Tokyo, Tokyo, Japan) by using 0.2 U/ml in 0.01 M Tris-acetate buffer, pH 8.0, for 16 h at room temperature. Protein concentration was determined by the method of Lowry, Rosebrough, Farr, and Randall (17 (10) was used. The released radioactivity migrated as free sulfate. However, chromatography on Sephadex G-25 was found to be more reproducible. An aliquot was chromatographed on a Sephadex column, G-25 (180 X 1.0 cm), by using 0.15 M NaCl in 15% ethyl alcohol as eluent. The included fractions, which contained inorganic sulfate, were counted in a Packard Tricarb Liquid Scintillation Spectrometer (Packard Instrument Co., Inc., Downers Grove, Ill.). The scintillation mixture contained 0.5 ml of the sample with 10 ml of Permafluor (Packard Instrument Co.) and 1 ml of Bio-Solv BBS-3 (Beckman Instruments, Inc., Fullerton, Calif.).
a-N-Acetylglucosaminidase was assayed with the phenyla-N-acetylglucosamine (a gift from Dr. B. Weissmann) as a substrate. p-N-Acetylhexosaminidase and fi-galactosidase were assayed with p-nitrophenyl derivatives (Sigma Chemical Co.) as described by Weissmann, Rowlin, Marshall, and Freiderici (18) .
RESULTS
Isolation of heparan sulfate. In experiments with normal fibroblasts, 1.6 and 2.0 mg of GAG were isolated from 40-60 plates, each plate containing about 1.6 X 107 cells with a dry wt of about 12-15 mg. Heparan sulfate comprised 1.25% of the total GAG. This estimation is based on the data in Table I indicating that the N-sulfated hexosamine in the purified heparan sulfate is about 40% of the total hexosamine samples which contained sufficient material for adequate analyses. The amounts of purified heparan sulfate isolated from normal fibroblasts were insufficient for determination of optical rotation. The medium collected from a 3-wk period of biweekly feeding of the cells contained small quantities of GAG, 0.3 mg/plate. The GAG isolated from the medium migrated, as does hyaluronic acid on electrophoresis with Sepraphore III. No Nsulfated hexosamine was demonstrable in this fraction. The medium supplemented with fetal calf serum and calf serum contains small amounts of hyaluronic acid and chondroitin sulfate but no detectable heparan sulfate (6). extract beyond that level did not increase the amount of 'SOQ released after 18 h of incubation (Fig. 2) .
Extracts of fibroblasts and liver from patients with Sanfilippo A syndrome demonstrated less than 10% of the activity of extracts of normal fibroblasts and fibroblasts of patients with other mucopolysaccharidoses (Table II) . When the same extracts were assayed for a-N-acetylglucosaminidase (Table III) and other lysosomal glycosidases (Table IV) , the, activities were found to be normal except for the expected deficiency of a-N-acetylglucosaminidase in Sanfilippo B samples.
DISCUSSION
Several studies (19) (20) (21) have indicated that heparan sulfates are a family of GAG which contain N-sulfated and N-acetylated glucosamine D-glucuronic acid and L-iduronic acid in varying proportions (22) . Recent studies (23, 24) have demonstrated that some of the L-iduronic acid groups are sulfated. Although chemically similar, the heparan sulfates differ from heparin in their lack of anticoagulant properties, lower Nsulfate, and total sulfate content. Certain fractions of heparan sulfates show lipoprotein-lipase-releasing activity and prevent dietary-induced atherosclerosis in rabbits (25) . The exact function of the heparan sulfates is unknown, though reports indicate their presence in many cell types (4-6) which might suggest a general function in cell physiology. A role in the division of cells for heparin and "heparin-like" compounds has been suggested by Heilbrunn (26) and Kinoshita (27) . Lipmann (28) has noted an effect of heparin on division of cells in culture.
In contrast to the excretion of both dermatan sulfate and heparan sulfate in Hurler's and Hunter's syndromes, only heparan sulfate is excreted in the Sanfilippo syndromes. Heparan sulfate and heparin have two unique linkages not present in dermatan sulfate, a-N-acetylglucosamine and glucosamine N-sulfate. The fact that deficiency of the two hydrolases concerned with degradation of these linkages produces a similar phenotype is, therefore, fully consistent with structural considerations. The Sanfilippo syndromes are characterized by severe mental retardation. Kapan (29) has suggested that accumulation of heparan sulfate is correlated with mental retardation. Perhaps this is related to the relatively high synthesis of this GAG by glial cells (6) . The results reported here add to the accumulating knowledge that the mucopolysaccharidoses result from genetically determined diminished activity of specific hydrolases required for degradation of GAG. Hurler's and Scheie's syndromes show a deficiency of a-L-iduronidase (30-32); Sanfilippo A syndrome, a deficiency of heparan sulfate N-sulfamidase (12, 13); Sanfilippo B. a deficiency of a-N-acetylglucosaminidase (9, 18); Hunter's syndrome, a deficiency of idurono-sulfate sulfatase (33) (34) (35) ; and Morquio's syndrome, a deficiency of chondroitin sulfate N-acetylhexosamine sulfate sulfatase (36) . An additional syndrome has been reported to demonstrate absence of 8-glucuronidase (37) . There is evidence of a diminished arylsulfatase B activity in Maroteaux-Lamy syndrome (38) , although the defect (18) . in degradation of the accumulated dermatan sulfate in this syndrome remains to be elucidated.
